Kanurra

Based in the US, Kanurra, Inc. operates a pass-through pharmacy benefit manager for small and midsize self-funded and level-funded employers, providing transparent drug pricing, claim-level auditability, rebate pass-through, and pharmacy-benefit administration. Kanurra, Inc. was founded in 2026 by Semih Gultekin, who serves as founder and CEO. The company is headquartered in New York, New York. Kanurra provides pharmacy benefit management for self-funded and level-funded employers and the brokers, advisors, and third-party administrators that serve them. Its pass-through model itemizes pharmacy acquisition costs, dispensing fees, and manufacturer rebates at claim level. Kanurra credits captured rebates to employer plans, applies no drug spread or markup, and supports real-time claim auditing. The platform also provides AI-assisted prior authorization with clinician escalation, disruption analysis before implementation, existing pharmacy-network continuity, eligibility and member communications, and a named contact at go-live. Kanurra's revenue is generated from a flat per-member-per-month administrative fee, disclosed in client contracts. This approach eliminates hidden costs typically associated with traditional PBMs, such as spread pricing and retained rebates. When processing a claim, employers are charged the actual acquisition cost of medications, plus a nominal dispensing fee, without additional markups from Kanurra. This pricing model ensures employers retain 100% of any manufacturer rebates received, reinforcing the company's transparency and cost-efficiency commitment. In July 2026, Kanurra, Inc. The company plans to expand its service offerings and enter new markets, although specific regions have not been disclosed.

1. Seed

   Jul 27, 2026

   Amount

   $6.3M

   Investors

   Locked